In summary, both TSGs ARHGEF12 and APAF1 expression were downregulated in colon cancer and could be reactivated by CUR, and upregulated ARHGEF12 and APAF1 may be associated with favorable prognosis of patients. Here, ARHGEF12 is linked to malignant colon neoplasm.